SSTR5 and breast carcinoma: The prevalence of SSTR5-TMD4 mRNA in samples of breast cancers classified as G3 was detected at 28–49%, and their presence is related with the absence of immunoreactivity to p53, estrogen receptor and Her2neu, and lymph node metastases [175].